Home > > > > Report Detail

Global Viral Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Publisher Name :
Date: 07-Dec-2023
No. of pages: 124

Market Overview of Global Viral Vaccines market:

According to our latest research, the global Viral Vaccines market looks promising in the next 5 years. As of 2022, the global Viral Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.

This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Viral Vaccines market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

Key Takeaways from the Global Viral Vaccines Market Report:

Market Size Estimates: Viral Vaccines market size estimation in terms of value and sales volume from 2018-2028

Market Trends and Dynamics: Viral Vaccines market drivers, opportunities, challenges, and risks

Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Viral Vaccines market

Segment Market Analysis: Viral Vaccines market value and sales volume by type and by application from 2018-2028

Regional Market Analysis: Viral Vaccines market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa

Country-level Studies on the Viral Vaccines Market: Revenue and sales volume of major countries in each region

Viral Vaccines Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.

Trade Flow: Import and export volume of the Viral Vaccines market in major regions.

Viral Vaccines Industry Value Chain: Viral Vaccines market raw materials & suppliers, manufacturing process, distributors, downstream customers

Viral Vaccines Industry News, Policies & Regulations

Key players in the global Viral Vaccines market are covered in Chapter 12:

Emergent BioSolutions Inc.

GlaxoSmithKline plc

Novavax, Inc.

Serum institute of India Private Limited

Seqirus (CSL Limited)

Merck & Co., Inc.

Novartis, Inc.

Sanofi

Pfizer, Inc.

AstraZeneca plc

In Chapter 2 and Chapter 15.1, based on types, the Viral Vaccines market from 2018 to 2028 is primarily split into:

Attenuated Vaccine

Inactivated Vaccine

In Chapter 3 and Chapter 15.2, based on applications, the Viral Vaccines market from 2018 to 2028 covers:

Hospital

Clinics

Physician's Office

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:

North America (Covered in Chapter 7)

United States

Canada

Asia-Pacific (Covered in Chapter 8)

China

Japan

India

South Korea

Southeast Asia

Australia

Others

Europe (Covered in Chapter 9)

Germany

France

UK

Italy

Spain

Russia

Poland

Others

Latin America (Covered in Chapter 10)

Mexico

Brazil

Argentina

Others

Middle East and Africa (Covered in Chapter 11)

GCC Countries

Africa

Others

The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.

In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.

Chapter Outline

This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 starts the report with an overview of the Viral Vaccines market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.

Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.

Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.

Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.

Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.

Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.

Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.

Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.

Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.

Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.

Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Viral Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Table of Content

1 Viral Vaccines Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Viral Vaccines Market Size (2018-2028)
1.3.1 Global Viral Vaccines Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Viral Vaccines Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Viral Vaccines Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Viral Vaccines Historic Revenue ($) by Type (2018-2023)
2.2 Global Viral Vaccines Historic Sales Volume by Type (2018-2023)
2.3 Attenuated Vaccine Sales and Price (2018-2023)
2.4 Inactivated Vaccine Sales and Price (2018-2023)

3 Global Viral Vaccines Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Viral Vaccines Historic Revenue ($) by Application (2018-2023)
3.2 Global Viral Vaccines Historic Sales Volume by Application (2018-2023)
3.3 Hospital Sales, Revenue and Growth Rate (2018-2023)
3.4 Clinics Sales, Revenue and Growth Rate (2018-2023)
3.5 Physician's Office Sales, Revenue and Growth Rate (2018-2023)
3.6 Others Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Viral Vaccines Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Viral Vaccines Industry News
4.7.2 Viral Vaccines Industry Policies

5 Global Viral Vaccines Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Viral Vaccines Sales Volume by Region (2018-2023)
5.2 Global Viral Vaccines Market Revenue ($) by Region (2018-2023)

6 Global Viral Vaccines Import Volume and Export Volume by Major Regions
6.1 Global Viral Vaccines Import Volume by Region (2018-2023)
6.2 Global Viral Vaccines Export Volume by Region (2018-2023)

7 North America Viral Vaccines Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Viral Vaccines Sales Volume and Growth Rate (2018-2023)
7.2 North America Viral Vaccines Market Trends Analysis Under Global Inflation
7.3 North America Viral Vaccines Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Viral Vaccines Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific Viral Vaccines Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Viral Vaccines Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Viral Vaccines Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Viral Vaccines Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Viral Vaccines Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Viral Vaccines Revenue ($) and Growth Rate (2018-2023)

9 Europe Viral Vaccines Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Viral Vaccines Sales Volume and Growth Rate (2018-2023)
9.2 Europe Viral Vaccines Market Trends Analysis Under Global Inflation
9.3 Europe Viral Vaccines Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Viral Vaccines Revenue ($) and Growth Rate (2018-2023)

10 Latin America Viral Vaccines Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Viral Vaccines Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Viral Vaccines Market Trends Analysis Under Global Inflation
10.3 Latin America Viral Vaccines Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Viral Vaccines Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa Viral Vaccines Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Viral Vaccines Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Viral Vaccines Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Viral Vaccines Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Viral Vaccines Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Viral Vaccines Revenue ($) and Market Share of Key Players
12.1.2 Global Viral Vaccines Sales Volume and Market Share of Key Players
12.1.3 Global Viral Vaccines Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Emergent BioSolutions Inc. Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Emergent BioSolutions Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 GlaxoSmithKline plc Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 GlaxoSmithKline plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Novavax, Inc. Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Novavax, Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Serum institute of India Private Limited Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Serum institute of India Private Limited Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Seqirus (CSL Limited) Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Seqirus (CSL Limited) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Merck & Co., Inc. Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Merck & Co., Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Novartis, Inc. Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Novartis, Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Sanofi Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Sanofi Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Pfizer, Inc. Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Pfizer, Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 AstraZeneca plc Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 AstraZeneca plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Viral Vaccines Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Viral Vaccines
13.3.3 Raw Material Cost of Viral Vaccines
13.3.4 Labor Cost of Viral Vaccines
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Viral Vaccines Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Viral Vaccines Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Viral Vaccines Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Viral Vaccines Sales Volume Forecast by Type (2023-2028)
15.2 Global Viral Vaccines Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Viral Vaccines Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Viral Vaccines Sales Volume Forecast by Application (2023-2028)
15.3 Global Viral Vaccines Sales Volume Forecast by Region (2023-2028)
15.4 Global Viral Vaccines Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion

List of Tables and Figures

Figure Viral Vaccines Picture
Table Viral Vaccines Definition
Table Description and Definitions
Figure Attenuated Vaccine Features
Figure Inactivated Vaccine Features
Table Description and Definitions
Figure Hospital
Figure Clinics
Figure Physician's Office
Figure Others
Figure North America Viral Vaccines Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific Viral Vaccines Revenue ($) and Growth Rate (2018-2028)
Figure Europe Viral Vaccines Revenue ($) and Growth Rate (2018-2028)
Figure Latin America Viral Vaccines Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa Viral Vaccines Revenue ($) and Growth Rate (2018-2028)
Figure Global Viral Vaccines Revenue ($) and Growth Rate (2018-2028)
Figure Global Viral Vaccines Sales Volume and Growth Rate (2018-2028)
Table Global Viral Vaccines Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global Viral Vaccines Historic Revenue ($) Share by Type (2018-2023)
Table Global Viral Vaccines Historic Sales Volume by Type (2018-2023)
Table Global Viral Vaccines Historic Sales Volume Share by Type (2018-2023)
Figure Global Attenuated Vaccine Sales and Growth Rate (2018-2023)
Figure Global Attenuated Vaccine Price (2018-2023)
Figure Global Inactivated Vaccine Sales and Growth Rate (2018-2023)
Figure Global Inactivated Vaccine Price (2018-2023)
Table Global Viral Vaccines Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global Viral Vaccines Historic Revenue ($) Share by Application (2018-2023)
Table Global Viral Vaccines Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global Viral Vaccines Historic Sales Volume Share by Application (2018-2023)
Figure Global Hospital Sales and Growth Rate (2018-2023)
Figure Global Hospital Revenue and Growth Rate (2018-2023)
Figure Global Clinics Sales and Growth Rate (2018-2023)
Figure Global Clinics Revenue and Growth Rate (2018-2023)
Figure Global Physician's Office Sales and Growth Rate (2018-2023)
Figure Global Physician's Office Revenue and Growth Rate (2018-2023)
Figure Global Others Sales and Growth Rate (2018-2023)
Figure Global Others Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for Viral Vaccines Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global Viral Vaccines Sales Volume by Region (2018-2023)
Table Global Viral Vaccines Sales Volume Share by Region (2018-2023)
Table Global Viral Vaccines Market Revenue ($) by Region (2018-2023)
Table Global Viral Vaccines Market Revenue ($) Share by Region (2018-2023)
Table Global Viral Vaccines Import Volume by Region (2018-2023)
Table Global Viral Vaccines Export Volume by Region (2018-2023)
Figure North America Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure North America Viral Vaccines Sales Volume and Growth Rate (2018-2023)
Table North America Viral Vaccines Market Trends Analysis Under Global Inflation
Table North America Viral Vaccines Revenue ($) by Country (2018-2023)
Table North America Viral Vaccines Sales Volume by Country (2018-2023)
Figure United States Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Canada Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Viral Vaccines Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific Viral Vaccines Market Trends Analysis Under Global Inflation
Table Asia Pacific Viral Vaccines Revenue ($) by Country (2018-2023)
Table Asia Pacific Viral Vaccines Sales Volume by Country (2018-2023)
Figure China Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Japan Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure India Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure South Korea Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia Viral Vaccines Revenue ($) by Country (2018-2023)
Figure Australia Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Europe Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Europe Viral Vaccines Sales Volume and Growth Rate (2018-2023)
Table Europe Viral Vaccines Market Trends Analysis Under Global Inflation
Table Europe Viral Vaccines Revenue ($) by Country (2018-2023)
Table Europe Viral Vaccines Sales Volume by Country (2018-2023)
Figure Germany Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure France Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Italy Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Spain Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Russia Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Poland Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Viral Vaccines Sales Volume and Growth Rate (2018-2023)
Table Latin America Viral Vaccines Market Trends Analysis Under Global Inflation
Table Latin America Viral Vaccines Revenue ($) by Country (2018-2023)
Table Latin America Viral Vaccines Sales Volume by Country (2018-2023)
Figure Mexico Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Brazil Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Argentina Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Viral Vaccines Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa Viral Vaccines Market Trends Analysis Under Global Inflation
Table Middle East and Africa Viral Vaccines Revenue ($) by Country (2018-2023)
Table Middle East and Africa Viral Vaccines Sales Volume by Country (2018-2023)
Figure GCC Countries Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Figure Africa Viral Vaccines Revenue ($) and Growth Rate (2018-2023)
Table Global Viral Vaccines Revenue ($) of Key Players (2018-2023)
Table Global Viral Vaccines Revenue ($) Share of Key Players (2018-2023)
Table Global Viral Vaccines Sales Volume of Key Players (2018-2023)
Table Global Viral Vaccines Sales Volume Share of Key Players (2018-2023)
Table Global Viral Vaccines Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table Emergent BioSolutions Inc. Company Profiles
Table Product Profiles and Application
Table Emergent BioSolutions Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Emergent BioSolutions Inc. Production and Growth Rate
Figure Emergent BioSolutions Inc. Value ($) Market Share 2018-2023
Table GlaxoSmithKline plc Company Profiles
Table Product Profiles and Application
Table GlaxoSmithKline plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure GlaxoSmithKline plc Production and Growth Rate
Figure GlaxoSmithKline plc Value ($) Market Share 2018-2023
Table Novavax, Inc. Company Profiles
Table Product Profiles and Application
Table Novavax, Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Novavax, Inc. Production and Growth Rate
Figure Novavax, Inc. Value ($) Market Share 2018-2023
Table Serum institute of India Private Limited Company Profiles
Table Product Profiles and Application
Table Serum institute of India Private Limited Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Serum institute of India Private Limited Production and Growth Rate
Figure Serum institute of India Private Limited Value ($) Market Share 2018-2023
Table Seqirus (CSL Limited) Company Profiles
Table Product Profiles and Application
Table Seqirus (CSL Limited) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Seqirus (CSL Limited) Production and Growth Rate
Figure Seqirus (CSL Limited) Value ($) Market Share 2018-2023
Table Merck & Co., Inc. Company Profiles
Table Product Profiles and Application
Table Merck & Co., Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Merck & Co., Inc. Production and Growth Rate
Figure Merck & Co., Inc. Value ($) Market Share 2018-2023
Table Novartis, Inc. Company Profiles
Table Product Profiles and Application
Table Novartis, Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Novartis, Inc. Production and Growth Rate
Figure Novartis, Inc. Value ($) Market Share 2018-2023
Table Sanofi Company Profiles
Table Product Profiles and Application
Table Sanofi Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2018-2023
Table Pfizer, Inc. Company Profiles
Table Product Profiles and Application
Table Pfizer, Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Value ($) Market Share 2018-2023
Table AstraZeneca plc Company Profiles
Table Product Profiles and Application
Table AstraZeneca plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure AstraZeneca plc Production and Growth Rate
Figure AstraZeneca plc Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of Viral Vaccines
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of Viral Vaccines with Contact Information
Figure Production Process of Viral Vaccines
Figure Manufacturing Cost Structure of Viral Vaccines
Table Major Distributors of Viral Vaccines with Contact Information
Table Major Downstream Buyers of Viral Vaccines with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global Viral Vaccines Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global Viral Vaccines Revenue ($) Share Forecast by Type (2023-2028)
Table Global Viral Vaccines Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global Viral Vaccines Sales Volume Share Forecast by Type (2023-2028)
Table Global Viral Vaccines Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global Viral Vaccines Revenue ($) Share Forecast by Application (2023-2028)
Table Global Viral Vaccines Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global Viral Vaccines Sales Volume Share Forecast by Application (2023-2028)
Table Global Viral Vaccines Sales Volume Forecast by Region (2023-2028)
Table Global Viral Vaccines Sales Volume Share Forecast by Region (2023-2028)
Table Global Viral Vaccines Revenue ($) Forecast by Region (2023-2028)
Table Global Viral Vaccines Revenue ($) Share Forecast by Region (2023-2028)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs